gdc
Hero of HopePatient StoriesOvarian Cancer

The Finalist Hero of Hope Patient Awards: Susan Leighton

Video Library – September 4, 2015
Recommended For You
Breast CancerPatient Stories
My Story: Male Breast Cancer and Waldenström's Macroglobulinemia
By Edward J. Sawa
Edward Sawa was waking up with headaches that disrupted his daily activities and ended up being diagnosed with Waldenström’s macroglobulinemia and breast cancer. Read the lessons he’s learned as a male with breast cancer.
Breast CancerCONQUER CamPatient Stories
CONQUER Cam: A Spotlight on Ed Sawa
Ed Sawa, a 65-year-old male breast cancer survivor, describes his journey through treatment with his support system by his side. Ed hopes that by sharing his story he can help men better understand the possibility of being diagnosed with breast cancer.
FDA Approvals, News & UpdatesOvarian Cancer
Zejula Approved as Once-Daily Treatment Option in Women with Advanced Ovarian Cancer
Women with advanced ovarian cancer now have a new once-daily treatment option. In April 2020, the Food and Drug Administration (FDA) approved Zejula (niraparib) for the maintenance treatment of all women with advanced ovarian cancer (including epithelial cancer, fallopian tube cancer, and primary peritoneal cancer) who have responded well to first-line chemotherapy. Maintenance therapy is the treatment of cancer with medication, typically following a first round of treatment (in this case, platinum-based chemotherapy).
Ovarian Cancer
Drugs for Ovarian Cancer
Here are the drugs and financial support services available to patients receiving treatment for Ovarian Cancer.
Last modified: October 8, 2017

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country